Sang Joon Lee Selected Research

CT-P6

8/2021	Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial.
1/2017	CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang Joon Lee Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 06/2003
21	Rheumatoid Arthritis 11/2022 - 10/2013
8	Endophthalmitis (Ophthalmia) 11/2021 - 02/2013
6	Breast Neoplasms (Breast Cancer) 08/2021 - 09/2008
6	Inflammation (Inflammations) 01/2019 - 09/2016
5	Ankylosing Spondylitis 01/2021 - 10/2013
5	Stomach Neoplasms (Stomach Cancer) 12/2018 - 09/2015
5	Malaria 11/2016 - 12/2013
4	Infections 11/2021 - 08/2015
4	Macular Edema 01/2021 - 06/2011
4	Crohn Disease (Crohn's Disease) 01/2021 - 01/2015
4	Cataract (Cataracts) 11/2020 - 04/2015
4	Neoplasm Metastasis (Metastasis) 02/2017 - 09/2008
4	Carcinoma (Carcinomatosis) 09/2015 - 03/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2014 - 09/2012
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 08/2017
3	Macular Degeneration (Age-Related Maculopathy) 11/2021 - 05/2015
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2015
3	Ulcerative Colitis 01/2021 - 01/2015
3	Hypertension (High Blood Pressure) 01/2020 - 12/2012
3	Embolism (Embolus) 09/2019 - 01/2016
3	Wounds and Injuries (Trauma) 06/2018 - 12/2013
3	Pathologic Constriction (Stenosis) 01/2017 - 04/2013
3	Neovascular Glaucoma 08/2014 - 03/2009
2	COVID-19 04/2022 - 10/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 02/2021 - 07/2009
2	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2020 - 07/2013
2	Dehydration (Water Stress) 02/2020 - 12/2010
2	Diabetes Mellitus 01/2020 - 02/2016
2	Hemorrhage 01/2020 - 06/2018
2	Retinal Degeneration 12/2019 - 01/2018
2	Pain (Aches) 06/2018 - 01/2017
2	Vascular Diseases (Vascular Disease) 08/2017 - 07/2014
2	Neutropenia 08/2017 - 01/2017
2	Adenocarcinoma 07/2017 - 09/2015
2	Fibrosis (Cirrhosis) 01/2017 - 07/2016
2	Splenomegaly 11/2016 - 10/2015
2	Carcinogenesis 07/2016 - 06/2003
2	Retinal Detachment (Retinal Detachments) 10/2012 - 09/2008
2	Colonic Neoplasms (Colon Cancer) 08/2011 - 02/2011

Drug/Important Bio-Agent (IBA)

20	Biosimilar PharmaceuticalsIBA 08/2021 - 10/2013
14	CT-P13IBA 01/2021 - 10/2013
11	Pharmaceutical PreparationsIBA 08/2021 - 01/2013
11	Infliximab (Remicade)FDA Link 01/2021 - 10/2013
10	CT-P10IBA 01/2022 - 01/2017
10	Rituximab (Mabthera)FDA Link 01/2022 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2015
5	Retinaldehyde (Retinal)IBA 12/2019 - 03/2009
5	FlavonoidsIBA 08/2018 - 12/2015
4	Trastuzumab (Herceptin)FDA Link 08/2021 - 01/2017
4	Bevacizumab (Avastin)FDA Link 09/2015 - 06/2009
3	Adalimumab (Humira)FDA Link 11/2022 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 07/2013
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2015
3	Biological ProductsIBA 01/2019 - 01/2015
3	GoldIBA 06/2015 - 01/2013
2	CT-P17IBA 11/2022 - 01/2021
2	regdanvimabIBA 04/2022 - 10/2021
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021 - 01/2020
2	CT-P6IBA 08/2021 - 01/2017
2	Retinal Pigments (Pigments, Visual)IBA 01/2021 - 04/2016
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2021
2	Moxifloxacin (Avelox)FDA Link 01/2021 - 01/2019
2	afliberceptIBA 01/2020 - 03/2017
2	Ceftazidime (Fortum)FDA LinkGeneric 06/2019 - 02/2013
2	Vancomycin FDA LinkGeneric 06/2019 - 02/2013
2	Biomarkers (Surrogate Marker)IBA 12/2018 - 11/2017
2	CaspasesIBA 01/2018 - 04/2017
2	Matrix Metalloproteinases (MMPs)IBA 02/2017 - 03/2014
2	GenisteinIBA 11/2016 - 10/2015
2	Glutathione (Reduced Glutathione)IBA 09/2016 - 12/2015
2	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 02/2016
2	Antimalarials (Antimalarial Agents)IBA 11/2015 - 12/2013
2	Coloring Agents (Dyes)IBA 08/2015 - 01/2015
2	CollagenIBA 03/2015 - 07/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 03/2011
2	matrigelIBA 12/2013 - 03/2011
2	Fluorescein (Funduscein)FDA LinkGeneric 12/2012 - 09/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2012 - 03/2011
2	EnzymesIBA 03/2011 - 06/2003
1	Oxygen (Dioxygen)IBA 04/2022
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021

Therapy/Procedure

12	Therapeutics 04/2022 - 03/2009
7	Injections 12/2020 - 05/2015
4	Intravitreal Injections 11/2020 - 02/2013
4	Vitrectomy 04/2015 - 10/2012
3	Neoadjuvant Therapy 08/2021 - 01/2017
3	Synchrotrons 01/2016 - 03/2013
2	Radiotherapy 02/2021 - 02/2012
2	Fluid Therapy (Oral Rehydration Therapy) 02/2020 - 12/2010
2	Biological Therapy 01/2019 - 08/2017
2	Drug Therapy (Chemotherapy) 01/2014 - 02/2012
2	Lasers (Laser) 04/2013 - 09/2008
2	Photochemotherapy (Photodynamic Therapy) 10/2009 - 07/2009
2	Light Coagulation 09/2008 - 12/2005
1	Intraocular Lenses (Intraocular Lens) 11/2021
1	Sutures (Suture) 11/2021